Thomas F. Gajewski to src-Family Kinases
This is a "connection" page, showing publications Thomas F. Gajewski has written about src-Family Kinases.
Connection Strength
0.421
-
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma. Invest New Drugs. 2013 Jun; 31(3):769-73.
Score: 0.421
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.